Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group

Patients with soft tissue sarcoma (STS), even after complete local disease control, often relapse locally or with distant metastases. This multicenter phase II study was conducted to evaluate the safety and efficacy of the combination of pegylated liposomal doxorubicin (PLD) and paclitaxel, as first...

Descripción completa

Detalles Bibliográficos
Autores principales: Bafaloukos, D, Papadimitriou, C, Linardou, H, Aravantinos, G, Papakostas, P, Skarlos, D, Kosmidis, P, Fountzilas, G, Gogas, H, Kalofonos, C, Dimopoulos, A M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409958/
https://www.ncbi.nlm.nih.gov/pubmed/15494721
http://dx.doi.org/10.1038/sj.bjc.6602148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409958/
https://www.ncbi.nlm.nih.gov/pubmed/15494721
http://dx.doi.org/10.1038/sj.bjc.6602148

Ejemplares similares